Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.

Ivayla RobertsMarina Wright MuelasJoseph M TaylorAndrew S DavisonYun XuJustine M GrixtiNigel GottsAnatolii SorokinRoyston GoodacreDouglas B Kell

Published in: Metabolomics : Official journal of the Metabolomic Society (2021)

Prognostic tests based on the markers discussed in this paper could allow improvement in the planning of COVID-19 patient treatment.

Keyphrases